600763:SSETopchoice Medical Corp. Class A Analysis
Data as of 2026-05-29 - not real-time
CN¥37.41
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading below its short‑term, mid‑term and long‑term moving averages, and the MACD shows a bearish crossover with a negative histogram. RSI sits in the lower‑mid range, hinting at modest oversold pressure, while recent volatility has been elevated. Valuation pressure: The market price is well above the discounted cash‑flow estimate and the price‑to‑earnings multiple exceeds the industry average, indicating the stock is currently overvalued.
Fundamental backdrop: The company generates solid margins and a healthy return on equity, supports a sustainable dividend with a comfortable payout ratio, and carries a moderate debt load relative to cash. Low beta suggests limited market‑wide price swings, but geographic concentration in China adds a layer of macro risk. Overall, the picture is one of strong fundamentals weighed down by a pricey market valuation and bearish technical signals.
Fundamental backdrop: The company generates solid margins and a healthy return on equity, supports a sustainable dividend with a comfortable payout ratio, and carries a moderate debt load relative to cash. Low beta suggests limited market‑wide price swings, but geographic concentration in China adds a layer of macro risk. Overall, the picture is one of strong fundamentals weighed down by a pricey market valuation and bearish technical signals.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below all moving averages
- bearish MACD momentum
- high recent volatility
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- overvaluation relative to fundamentals
- steady cash flow and dividend sustainability
- moderate debt profile
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- stable demand for dental services
- low market beta indicating defensive characteristics
- consistent dividend yield
Key Metrics & Analysis
Financial Health
Revenue Growth1.40%
Profit Margin17.27%
P/E Ratio33.4
ROE12.67%
ROA6.94%
Debt/Equity23.96
P/B Ratio3.8
Op. Cash FlowCN¥824.1M
Free Cash FlowCN¥365.9M
Industry P/E27.8
Technical Analysis
TrendBearish
RSI38.1
SupportCN¥35.80
ResistanceCN¥43.45
MA 20CN¥39.29
MA 50CN¥40.90
MA 200CN¥43.73
MACDBearish
VolumeStable
Fear & Greed Index93.11
Valuation
Fair ValueCN¥10.67
GradeOvervalued
TypeBlend
Dividend Yield1.24%
Risk Assessment
Beta0.02
Volatility27.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.